The Preclinical and Clinical Pharmacology of SK&F 104353, a Potent and Selective Peptidoleukotriene Receptor Antagonist
- 1 July 1991
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 629 (1) , 157-167
- https://doi.org/10.1111/j.1749-6632.1991.tb37973.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Elevated Levels of Leukotriene C4in Bronchoalveolar Lavage Fluid from Atopic Asthmatics after Endobronchial Allergen ChallengeAmerican Review of Respiratory Disease, 1990
- The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjectsJournal of Allergy and Clinical Immunology, 1988
- Release of leukotrienes in patients with bronchial asthmaJournal of Allergy and Clinical Immunology, 1988
- Leukotrienes and Airway ResponsesAmerican Review of Respiratory Disease, 1987
- Leukotrienes in health and diseaseThe FASEB Journal, 1987
- Airway Responsiveness to Leukotrienes C4 and D4 and to Methacholine in Patients with Asthma and Normal ControlsNew England Journal of Medicine, 1986
- Measurement of immunoreactive leukotriene C4 in blood of asthmatic childrenBiochemical and Biophysical Research Communications, 1985
- Formation and actions of leukotrienesPhysiological Reviews, 1984
- Bronchoconstrictor Effects of Leukotriene C in HumansScience, 1982
- Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.Proceedings of the National Academy of Sciences, 1981